HIV-1 entry occurs when CD4 binds to the HCV-1 gp120 glycoprotein on the cell surface which induces a conformational change to trigger additional co-receptor CCR5 to interact. In this paper, P.D. Kwong and co-workers identified CCR5-N terminus mimetic small molecule inhibitors using in silico screening and further characterized in viral entry inhibition assay.
No comments:
Post a Comment